01/31/2023
By Patricia Morena
“AbbVie’s Approach to Innovation via Venture Investing”
Register online
Date: Thursday, Feb. 16, 2023
Time: 9 a.m. EST
Free webinar
Presenter: Charles Kunsch, Managing Director, AbbVie Ventures
Charles Kunsch will provide insight into AbbVie’s approach for corporate venture investing.
Charles Kunsch is Managing Director at AbbVie Ventures, and an experienced pharmaceutical leader with >25 years of experience in pharmaceutical R&D, Business Development and Venture Investing. He has broad experience in sourcing, evaluation and transacting early-stage equity investments and business development partnerships through leveraging a well-established network of scientific and business professionals. Charles currently serves on the Boards of several venture capital backed companies including Aquinnah Pharmaceutcals, FireCyte Therapeutics, EndLyz Therapeutics, DG Medicines, Kojin Therapeutics, Accent Therapeutics and Quanta Therapeutics.
For more information, email Patricia_morena@uml.edu.